Proteomics International (ASX: PIQ) has expanded its research agreement with the University of Melbourne and the Royal Women’s Hospital (RWH), a leading centre for endometriosis research. The partnership has two clear streams: (1) additional clinical validation for Promarker®Endo—PIQ’s first-in-class blood test for diagnosing endometriosis—and (2) discovery work toward a tissue-specific, next-generation test using peritoneal fluid to improve disease localisation.

Investing wisely is crucial in today’s fast-changing financial landscape. With so many options available, it can be overwhelming to decide where to put your money. This guide will help you navigate the best promising investment trends and provide practical advice to make informed decisions. Whether you are a beginner or looking to diversify your portfolio, understanding these trends can help you maximize your returns.